The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems

Thorax. 1996 Jul;51(7):750-5. doi: 10.1136/thx.51.7.750.
No abstract available

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / physiopathology
  • Cystic Fibrosis / therapy
  • Deoxyribonucleases / pharmacology
  • Deoxyribonucleases / therapeutic use*
  • Drug Utilization
  • Humans
  • Lung / drug effects
  • Lung / physiopathology
  • Recombinant Proteins / therapeutic use
  • Sputum / drug effects

Substances

  • Recombinant Proteins
  • Deoxyribonucleases